These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 30223034
1. Porphyrins to restrict progression of pancreatic cancer by stabilizing KRAS G-quadruplex: In silico, in vitro and in vivo validation of anticancer strategy. Pattanayak R, Barua A, Das A, Chatterjee T, Pathak A, Choudhury P, Sen S, Saha P, Bhattacharyya M. Eur J Pharm Sci; 2018 Dec 01; 125():39-53. PubMed ID: 30223034 [Abstract] [Full Text] [Related]
2. Selective binding of a bioactive porphyrin-based photosensitizer to the G-quadruplex from the KRAS oncogene promoter. Caterino M, D'Aria F, Kustov AV, Belykh DV, Khudyaeva IS, Starseva OM, Berezin DB, Pylina YI, Usacheva T, Amato J, Giancola C. Int J Biol Macromol; 2020 Feb 15; 145():244-251. PubMed ID: 31870869 [Abstract] [Full Text] [Related]
3. Structure-based design and evaluation of synthetic porphyrin derivatives as G-quadruplex stabilizing anticancer agents. Bhadane RN, Meshram DB, Gilhotra RM. J Exp Ther Oncol; 2017 Nov 15; 12(2):103-111. PubMed ID: 29161777 [Abstract] [Full Text] [Related]
4. Critical role of hnRNP A1 in activating KRAS transcription in pancreatic cancer cells: A molecular mechanism involving G4 DNA. Cogoi S, Rapozzi V, Cauci S, Xodo LE. Biochim Biophys Acta Gen Subj; 2017 May 15; 1861(5 Pt B):1389-1398. PubMed ID: 27888145 [Abstract] [Full Text] [Related]
6. G-quadruplex formation within the promoter of the KRAS proto-oncogene and its effect on transcription. Cogoi S, Xodo LE. Nucleic Acids Res; 2006 May 15; 34(9):2536-49. PubMed ID: 16687659 [Abstract] [Full Text] [Related]
7. A G-quadruplex-binding compound showing anti-tumour activity in an in vivo model for pancreatic cancer. Ohnmacht SA, Marchetti C, Gunaratnam M, Besser RJ, Haider SM, Di Vita G, Lowe HL, Mellinas-Gomez M, Diocou S, Robson M, Šponer J, Islam B, Pedley RB, Hartley JA, Neidle S. Sci Rep; 2015 Jun 16; 5():11385. PubMed ID: 26077929 [Abstract] [Full Text] [Related]
14. Identification and characterization of a new G-quadruplex forming region within the kRAS promoter as a transcriptional regulator. Morgan RK, Batra H, Gaerig VC, Hockings J, Brooks TA. Biochim Biophys Acta; 2016 Feb 16; 1859(2):235-45. PubMed ID: 26597160 [Abstract] [Full Text] [Related]
15. Critical role of oncogenic KRAS in pancreatic cancer (Review). Liu J, Ji S, Liang C, Qin Y, Jin K, Liang D, Xu W, Shi S, Zhang B, Liu L, Liu C, Xu J, Ni Q, Yu X. Mol Med Rep; 2016 Jun 16; 13(6):4943-9. PubMed ID: 27121414 [Abstract] [Full Text] [Related]
18. Structural polymorphism within a regulatory element of the human KRAS promoter: formation of G4-DNA recognized by nuclear proteins. Cogoi S, Paramasivam M, Spolaore B, Xodo LE. Nucleic Acids Res; 2008 Jun 16; 36(11):3765-80. PubMed ID: 18490377 [Abstract] [Full Text] [Related]
19. The human AP-endonuclease 1 (APE1) is a DNA G-quadruplex structure binding protein and regulates KRAS expression in pancreatic ductal adenocarcinoma cells. Pramanik S, Chen Y, Song H, Khutsishvili I, Marky LA, Ray S, Natarajan A, Singh PK, Bhakat KK. Nucleic Acids Res; 2022 Apr 08; 50(6):3394-3412. PubMed ID: 35286386 [Abstract] [Full Text] [Related]